Press releases Image EN FR Corporate / 05.07.2012 Trading update July 5, 2012 Read more Trading update July 5, 2012
Press releases Image FR EN Proton Therapy / 29.06.2012 IBA to Install First Revolutionary Proteus®ONE Solution in Europe Read more IBA to Install First Revolutionary Proteus®ONE Solution in Europe
Press releases Image EN Proton Therapy / 19.06.2012 First patient in ProCure Proton Therapy center in New Jersey completes treatment successfully after a record breaking IBA install of equipment in 12 months Read more First patient in ProCure Proton Therapy center in New Jersey completes treatment successfully after a record breaking IBA install of equipment in 12 months
Press releases Image EN RadioPharma Solutions / 07.06.2012 The IBA IntegraLab® Team Supports the Penn PET Center for cGMP Compliance Read more The IBA IntegraLab® Team Supports the Penn PET Center for cGMP Compliance
Press releases Image EN FR RadioPharma Solutions / 05.06.2012 IBA Expands International Customer Base with Two New Major RadioPharmacy Contracts Read more IBA Expands International Customer Base with Two New Major RadioPharmacy Contracts
Press releases Image EN FR Corporate / 11.05.2012 Cisbio Bioassays Adds Three Cellular Kinase Assays to its Kinase Screening Platform Read more Cisbio Bioassays Adds Three Cellular Kinase Assays to its Kinase Screening Platform
Press releases Image FR EN Corporate / 08.05.2012 Trading update - First quarter 2012 Read more Trading update - First quarter 2012
Press releases Image EN Proton Therapy / 03.05.2012 Installation of IBA Proton System Begins at ATreP in Trento, Italy Read more Installation of IBA Proton System Begins at ATreP in Trento, Italy
Press releases Image EN FR Corporate / 26.04.2012 Information about a Partial Decision in the Process of Arbitration between STRIBA and WPE Read more Information about a Partial Decision in the Process of Arbitration between STRIBA and WPE
Press releases Image EN Corporate / 02.04.2012 IBA Closes its IBA Molecular Transaction with SK Capital and Revises its 2011 Financial Statements accordingly Read more IBA Closes its IBA Molecular Transaction with SK Capital and Revises its 2011 Financial Statements accordingly
